December 15, 2020
HHS purchases 100 million additional doses of Moderna’s COVID-19 vaccine
Editor's Note
The Department of Health and Human Services (HHS) announced on December 11 that it would purchase 100 million additional doses of Moderna’s COVID-19 vaccine.
The vaccine, which was developed by Moderna with scientists from the National Institute of Allergy and Infectious Diseases (NIAID), is scheduled for a December 17 review by the Food and Drug Administration. Anthony Fauci, MD, is director of NIAID.
The purchase doubles the amount of Moderna vaccine owned by the federal government to 200 million.
Free Daily News
- Opening keynote: Healthcare's 'Blockbuster Moment'—Innovation, Disruption, and the Future of Nursing
- Session: Using 16th century Samurai code to help leaders succeed
- Workshop: Mastering The Joint Commission standards and CMS regulations
- Workshop: The leadership shift—From managing tasks to leading with influence
- Simulation-based robotic surgery training boosts team confidence, communication
- Perioperative leaders gather at 2025 OR Manager Conference
- CMS launches 6-year model to curb wasteful Medicare spending with AI-driven reviews
- Report: Hospitals can cut anesthesia costs, burnout through tech-driven partnerships
- Study: One in four US healthcare workers faces food insecurity
- Digital decision aid boosts shared decision-making in knee replacement consultations
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement